tiprankstipranks
Trending News
More News >
Lyra Therapeutics (LYRA)
NASDAQ:LYRA
US Market

Lyra Therapeutics (LYRA) Income Statement

Compare
367 Followers

Lyra Therapeutics Income Statement

Last quarter (Q3 2025), Lyra Therapeutics's total revenue was $25.00K, a decrease of -87.18% from the same quarter last year. In Q3, Lyra Therapeutics's net income was $-5.98M. See Lyra Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.53M$ 1.56M$ 1.36M$ 285.00K$ 0.00
Gross Profit
$ 1.53M$ 1.56M$ 1.36M$ -29.41M$ -12.52M
Operating Expenses
$ 97.88M$ 68.68M$ 57.67M$ 14.21M$ 9.69M
Depreciation and Amortization
$ 471.00K$ 278.00K$ 1.07M$ 1.00M$ 95.00K
EBITDA
$ -60.26M$ -65.25M$ -53.92M$ -42.61M$ -22.11M
Operating Income
$ -96.35M$ -67.12M$ -56.31M$ -43.62M$ -22.21M
Other Income/Expenses
$ 2.95M$ 4.50M$ 1.04M$ 102.00K$ 82.00K
Pretax Income
$ -93.40M$ -62.62M$ -55.27M$ -43.51M$ -22.13M
Net Income
$ -93.44M$ -62.68M$ -55.28M$ -43.51M$ -22.13M
Per Share Metrics
Basic EPS
$ -1.43$ -1.26$ -1.83$ -3.35$ -2.59
Diluted EPS
$ -1.43$ -1.26$ -1.83$ -3.35$ -2.59
Weighted Average Shares Outstanding
65.11M 49.75M 30.24M 12.99M 8.55M
Weighted Average Shares Outstanding (Diluted)
65.11M 49.80M 30.24M 12.99M 8.59M
Currency in USD

Lyra Therapeutics Earnings and Revenue History